在阿佐キシ甲引起的急性肝衰竭期间肝病理的特征
Shadikchhya Maya Bhattarai1, Ashwin Jhawer1, Gabriel Frampton1
1Department of Internal Medicine, University of Texas at Austin Dell Medical School, Austin, TX 78701, United States.
World journal of gastroenterology
|April 4, 2025
概括
这项研究详细介绍了急性肝衰竭 (ALF) 中的分子变化,使用阿佐西甲 (AOM) 模型. 在AOM治疗小鼠中,炎症是最早的显著变化,其次是亡,氧化应激,亡和衰老.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 毒理学 毒理学 毒理学
- 分子病理学分子病理学
背景情况:
- 急性肝衰竭 (ALF) 是严重的肝损伤后肝功能的严重损失.
- 氧甲 (AOM) 鼠标模型复制了ALF和肝脏脑病变,但肝脏的分子病理仍未得到描述.
- 对AOM毒性的全面表征对于了解ALF的病原性至关重要.
研究的目的:
- 为了确定在AOM诱导的ALF进展期间导致肝损伤的分子病理.
- 为了阐明AOM诱导的ALF分子事件的时间序列.
主要方法:
- 在C57BL/6小鼠中使用AOM诱导ALF和肝脏脑病变.
- 在神经衰退的各个阶段收集肝脏组织.
- 评估肝损伤,CYP2E1表达,氧化应激,炎症,亡,亡和衰老.
主要成果:
- 随着小鼠进入昏迷,AOM注射导致肝硬化和肝损伤的增加.
- CYP2E1的表达减少,而氧化应激标志物 (甲,髓氧化酶) 增加.
- 在ALF进展过程中,炎症标志物 (CCL2,TNF-α),亡,亡和衰老都升高.
结论:
- 死亡,氧化应激,炎症,亡和衰老在AOM诱导的ALF中升高.
- 在这个ALF模型中,炎症是最早出现的显著分子变化.
- 这些发现提供了AOM诱导的肝损伤的详细分子概况.
相关概念视频
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Cirrhosis I: Introduction
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Hepatic Encephalopathy
DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...
Acute Pancreatitis II: Pathophysiology
The pathophysiology of acute pancreatitis centers on injury to pancreatic acinar cells, which initiates a cascade of harmful intracellular events.This injury leads to premature activation of trypsinogen to trypsin in the pancreas. Trypsin then activates other digestive enzymes, such as chymotrypsin, elastase, and phospholipase A2, which begin breaking down pancreatic tissue. The resulting autodigestion causes local inflammation, tissue swelling, hemorrhage, and fat necrosis.Injured acinar cells...


